High-Throughput Screening Identifies Novel ROS-Inducing Small Molecules as a Therapy for Treatment-Resistant Melanoma. (October 2022) - Stoffel, C.; Eichhoff, O.; Turko, P.; Cheng, P.; Briker, L.; Dzung, A.; Dummer, R.; Levesque, M.